Clinical Trial Update: Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating alvocidib in patients with relapsed/refractory acute myeloid leukemia after venetoclax-containing therapy; status terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Alvocidib (Flavopiridol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: TERMINATED | Results posted: 2022-10-19